LIM kinase-1/2 inhibitors (Cancer Research UK)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameLIM kinase-1/2 inhibitors (Cancer Research UK)
Drug Alias NameLIMK1/2 inhibitors (Cancer Research Technology)CRT-0105950CRT-105446CRT-0105446CRT-105950
ClassificationSmall molecules
Mechanisms of ActionLIM domain kinase 1 inhibitorsAnticancer protein kinase inhibitorsApoptosis stimulants +[4] 
TargetsLIM domain kinase 1LIM domain kinase 2
Therapy Area/IndicationsEye DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research TechnologyCancer Research UK
Active IndicationsN/A
Inactive IndicationsEye DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A